Abstract: A method of treating episodic and chronic nasal congestion of the human nasal passages is disclosed. The present invention combines use of decongestant nasal spray, saline nasal spray, and nasal dilator therapies with minimized risk of incurring rebound congestion. The method may be used as both preventative and withdrawal therapies for patients experiencing rebound congestion. Nasal dilators, decongestant nasal spray and saline nasal spray are provided in kit form whereby users may practice the method.

Abstract: A medical device, comprising a plastic film and a support structure, wherein the plastic film, per se, has insufficient intrinsic stability to retain a planar shape against standard gravity, the support structure supports an area of the plastic film such that at least 80% of an entire area of the plastic film is inhibited from deforming, regardless of orientation, in response to standard gravity, and the support structure is manually inseparable from the plastic film.

Abstract: A nasal dilator, comprising a plurality of laminated components, wherein each of the laminated components comprises a first major surface that faces in a first direction and a second major surface that faces in a second direction, the plurality of laminated components comprises at least one resilient member, each of the at least one resilient member comprises a first end at a first edge of the nasal dilator and a second end at a second edge of the nasal dilator, each of the at least one resilient member extends from the first end to the second end in a direction parallel to a longitudinal axis of the nasal dilator, the plurality of laminated components comprises a first component and a second component, an entirety of the second major surface of the first component is of a first color, an entirety of the second major surface of the second component is of a second color, and at least a portion of the second major surface of the first component and at least a portion of the second major surface of the second co

Abstract: A nasal dilator, comprising a plurality of laminated components, wherein each of the laminated components comprises a first major surface that faces in a first direction and a second major surface that faces in a second direction, the plurality of laminated components comprises a first component and a second component, the first component comprises a first region of a first color, the second component comprises a second region, the second region is a semi-transparent region of a second color, and the second region overlaps the first region such that the first color is visible via the second region and the second color alters a visual perception of the first color.

Abstract: Nasal dilators with improved comfort are formed as a laminate of layers: a resilient layer including a plurality of resilient members; and an engagement layer including one or both of a base layer and a cover layer. A portion of the dilator occupied by all of the resilient members plus the gap(s) between the resilient members has a total area, and the proportion of that area that is occupied or covered by the resilient members does not exceed 57%. Preferably, the proportion is lower than about 50%, and it may be as low as 30% in some embodiments.

Abstract: An external nasal dilator comprises resilient and engagement elements, and includes end regions adapted to engage tissues overlaying and adjacent first and second nasal passages of a human nose. Each end region includes a plurality of resilient spring finger components separated therebetween by engagement element tab extensions. The end regions are further adapted to extend around the anatomical depression formed by the alar crease adjacent each nostril. When in use the dilator stabilizes or expands said tissues and prevents or inhibits the nasal outer walls from drawing inward during breathing.